TrialJournal of translational medicine2018

Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.

Yoshiya Horimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.